POSTER SESSION II Monday, February 13, 2006   —  1:00 - 4:30 PM Exhibit Level GENITOURINARY PATHOLOGY 66 Significance of Denuded Urothelium in Papillary Urothelial Lesions (705) CL Owens, JI Epstein - The Johns Hopkins Hospital, Baltimore, MD 67 Inverted Urothelial Papillomas of the Prostatic Urethra (618) JI Epstein, TY Chan, SW Fine - Johns Hopkins University, Baltimore, MD 68 Utility of Polyclonal anti-PSA and High-molecular weight cytokeratin Immunohistochemistry in the Differentiation of Poorly Differentiated Prostatic Carcinoma from Urothelial Carcinoma (771) M Varma, B Jasani, PN Mathews, SN Datta, MB Amin - University Hospital of Wales, Cardiff, United Kingdom; University Hospital of Wales, Cardiff, United Kingdom; Emory University, Atlanta, GA 69 Topographical Distribution Of Prostatic Urothelial Carcinoma In Patients With Bladder Cancer: Implication For Transurethral Biopsy And Pathologic Examination (741) SS Shen, SP Lerner, B Muezzinoglu, LD Truong, TM Wheeler - The Methodist Hospital, Baylor College of Medicine, Houston, TX 70 In Situ Adenocarcinoma Of The Urinary Bladder (ISAB). Clinicopathological Features And Immunophenotype (682) A Lopez-Beltran, C Patriarca, R Montironi, RJ Luque, L Cheng - Cordoba University Medical School, Cordoba, Spain; Melegnano Hopital, Milan, Italy; Marche Region University, Ancona, Italy; Indiana University, Indianapolis, IN 71 Apoptosis Regulators In Superficial Urothelial Carcinoma: An Analysis Of Eleven Proteins Of The Caspase Family And The Inhibitor Of Apoptosis Protein (IAP) Family (781) W Yin, YT Zhang, N Chen, XQ Chen, J Gong, Q Zhou - West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan, China 72 Distinct DNA Methylation Profiles between Papillary and Non-papillary Bladder Urothelial Carcinoma (773) L Wang, D Weber, L Sercia, M Zhou, B Yang - Cleveland Clinic Foundation, Cleveland, OH 73 CD24 Is a Biomarker for Prognosis and Therapeutic Target in Bladder Cancer (750) SC Smith, MD Nitz, HF Frierson, D Theodorescu - University of Virginia, Charlottesville, VA 74 PSMA Expression In Different Pathologic Stages Of Urothelial Carcinoma Of The Bladder (703) S Olgac, H Al-Ahmadie, P Gregor, SK Tickoo, VE Reuter - Memorial Sloan-Kettering Cancer Center, New York, NY 75 Immunohistochemical Analysis Of The Micropapillary Variant Of Urothelial Carcinoma Of The Urinary Bladder (782) SS Yun, D Hamele-Bena, GX Tong - Columbia University Medical Center, New York, NY 76 Loss Of Heterozygosity (LOH) Analysis Of Muscle Invasive And Metastatic Urothelial Carcinoma (UC); Can We Predict Progression/Metastasis? (686) T McHale, J Richmond, C Trusky, G Mantha, JL Hunt, S Bastacky - University of Pittsburgh Medical Center, Pittsburgh, PA 77 Immunohistochemical Expression Of p63, GLUT1 And XIAP In Micropapillary Urothelial Carcinoma (654) MT Idrees, A Kafanas, L Gan, Y Huan, DE Burstein, PD Unger - Mount Sinai Sch of Med, New York, NY 78 Urachal Carcinoma: A Clinico-Pathologic Study Of 24 Cases (637) A Gopalan, DS Sharp, S Tickoo, H Herr, VE Reuter, S Olgac - Memorial Sloan-Kettering Cancer Center, New York, NY 79 A Comparison Of Papillary And Flat Urothelial Carcinoma Using LOH And MSI Analysis. (687) T McHale, J Richmond, J Balani, C Trusky, G Mantha, JL Hunt, R Dhir, A Parwani, F Monzon, S Bastacky - University of Pittsburgh Medical Center, Pittsburgh, PA 80 Prostatic Involvement by Urothelial and Prostatic Carcinoma: A Clinicopathological Analysis of 120 Consecutive Cystoprostatectomies (580) HA Al-Ahmadie, JA Pettus, SK Tickoo, BH Bochner, VE Reuter, S Olgac - Memorial Sloan-Kettering Cancer Center, New York, NY 81 Alternative Target Genes Contiguous to RB1 and p53 Involved in Clonal Expansion of in situ Urothelial Neoplasia (685) T Majewski, J Jeong, T Tuziak, S Samanta, TC Kuang, K Baggerly, B Czerniak - The University of Texas MD Anderson Cancer Center, Houston, TX 82 S100p: A Marker for Transitional Epithelium and Urothelial Carcinoma (650) JP Higgins, G Kaygusuz, L Wang, K Montgomery, V Mason, JD Brooks, M van de Rijn - Stanford University, Stanford, CA; University of Ankara, Ankara, Turkey 83 Molecular And Immunohistochemical Analysis Of The Prognostic Value Of Cell-Cycle Regulators In Urothelial Neoplasms Of The Bladder (681) A Llombart-Bosch, A Yurakh, JA Lopez-Guerrero, D Ramos, J Rubio, S Calabuig-FariZas, A Pellin, I Iborra, E Solsona-Narbon - University of Valencia, Fundacion Instituto Valenciano de Oncologia, Fundacion Instituto Valenciano de Oncologia, Valencia, Spain 84 Lymphovascular Invasion in Urothelial Carcinoma of the Bladder: Diagnostic Utilities and Biologic Implications of the Lymphovascular Markers CD34, CD31, and D2-40. (764) LD Truong, Q Zhai, JY Ro, S Shen - The Methodist Hospital, Baylor College of Medicine, Houston, TX; Weill Medical College of Cornell University, New York, NY 85 Tissue Fragments in Voided Urine are Unusual. How Concerning is this Statement? (699) TL Nicol, K Studeman - Johns Hopkins Bayview Medical Center, Baltimore, MD 86 High Grade Urothelial Carcinoma of the Renal Pelvis: Clinicopathologic Study of 108 Cases with Emphasis on Unusual Morphologic Variants (714) D Perez Montiel, PE Wakely, Jr, O Hes, M Michal, S Suster - Ohio State University; Instituto Nacional de Cancerologia, Mexico; University Hospital, Plzen, Czech Republic 87 Inflammatory Myofibroblastic Tumors Of Ureter: A Clinicopathologic And Immunohistochemical Study Of 3 Cases (661) L Kapusta, S Hussein, D Pilavdzic, D Driman, G MacLennan, JR Srigley - Credit Valley Hospital, Mississauga, ON, Canada; St Mary;s Hospital Center, Montreal, QC, Canada; University of Western Ontario, London, ON, Canada; University Hospitals of Cleveland, Cleveland, OH; McMaster University, Hamilton, ON, Canada 88 Sarcomas and Pseudosarcomas of the Urinary Bladder (753) P Spiess, RF Tibbs, T Tuziak, HB Grossman, B Czerniak - The University of Texas MD Anderson Cancer Center, Houston, TX 89 Urovysion Fish In Monitoring For Urothelial Carcinoma Recurrence After Cystectomy With Ileal Conduit/Neobladder. Identification Of An Important Technical Challenge From A Series Of 3533 Total Tests (693) EJ Milionis, PA Lewis, MJ Putzi, RL Roberts, JR Oppenheimer, SB Shappell - MOD Lab, Dallas, TX; OUR Lab, Nashville, TN 90 Improved Filter Monolayer Method for Urine Sediment Detection of Urothelial Carcinoma by FISH (690) I Meiers, H Singh, K Maramot, L Liu, J Qian, DG Bostwick - Bostwick Laboratories, Glen Allen, VA 91 Detection of Chromosomal Abnormalities In Voided Urine And Bladder Washes by FISH: A Close Look At 3784 Cases (584) AT Anthony, JA Thompson - US Labs, Irvine, CA 92 Adenomatoid Tumors Of The Female And Male Genital Tract Express D2-40 (632) ZGhorab, MA Khalifa, HJ Kahn - Sunnybrook & Women's College Health Sciences Centre, Toronto, ON, Canada 93 OCT4 Is Superior To CD30 In The Diagnosis Of Metastatic Embryonal Carcinomas After Chemotherapy (755) MT Sung, TD Jones, SD Beck, RS Foster, L Cheng - Indiana University, Indianapoli, IN; Chang-Gung Memorial Hospital, Kaohsiung, Taiwan 94 Clonal Origin of Metastatic Mature Teratomas (657) TD Jones, M Wang, TM Ulbright, JN Eble, SD Beck, RS Foster, C Conner, JJ Anagnostou, L Cheng - Indiana University, Indianapolis, IN 95 Xanthogranulomatous Epididymitis: Identification Of Bacterial Agents Using A PCR Method (672) KH Lee, CZ Piao, TW Kang, KJ Yoon, HJ Joo, C Choi - Chonnam National University Medical School, Gwangju, Korea; School of Medicine, Wonkwang University, Iksan, Jeollabuk-do, Korea; Ajou University School of Medicine, Suwon, Gyeonggi-do, Korea 96 Chronic Orchialgia: Histologic Findings in 23 Cases (745) JF Sherman, AA Elhosseiny, TD Trainer - University of Vermont/FAHC, Burlington, VT 97 The Role of Frozen Section in the Management of Intrascrotal Mass Lesions (667) P Kumar, PJR Shah, P Cuckow, DJ Ralph, S Minhas, AA Freeman - University College London, London, United Kingdom 98 M2A Antigen (Podoplanin) Distribution In Prepubertal and Adult Testes and Testicular Tumors (737) IA Sesterhenn, CJ Davis, B Furusato - AFIP, Washington, DC 99 Bilateral Testicular Germ Cell Tumors (778) A Yilmaz, T Cheng, A Oryschak, K Trpkov - Calgary Laboratory Services and University of Calgary; Tom Baker Cancer Centre and University of Calgary, Calgary, AB, Canada 100 Pure Teratoma Of The Testis In Adults (779) A Yilmaz, T Cheng, S Rasmussen, K Trpkov - Calgary Laboratory Services and University of Calgary, Tom Baker Cancer Centre, Calgary, AB, Canada 101 Expression Of MMP-2 And -9 Is Different According The Pattern Of Growth/Invasion In Penile Carcinoma (751) FA Soares, IW Cunha, G Cardoso, S Nonogaki, RSM Campos, A Lopes - Hospital do Cancer, Sao Paulo, SP, Brazil 102 Anatomical Levels Of Invasion And Tumor Thickness In Invasive Penile Squamous Cell Carcinoma (SCC) Of The Glans. A Proposal Of Modification Of The TNM System. (772) EF Velazquez, M Zanotti, M Acevedo, A Knofelmacher, JE Barreto, J Torres, A Chaux, AL Cubilla - New York University School of Medicine, New York, NY; Facultad de Ciencias Medicas Universidad Nacional de Asuncion, Instituto de Patologia e Investigacion, Asuncion, Paraguay 103 Histologic Grade is More Important Than Tumor Thickness as Predictor of Nodal Metastasis in Squamous Cell Carcinoma (SCC) of the Penis Invading 5-10 MM (611) AL Cubilla, A Chaux, M Zanotti, M Acevedo, A Knofelmacher, J Torres, JE Barreto, EF Velazquez - Facultad de Ciencias Medicas Universidad Nacional de Asuncion; Instituto de Patologia e Investigacion, Asuncion, Paraguay; NYU School of Medicine, New York, NY 104 Prognostic Index In 110 Invasive Squamous Cell Carcinoma Of The Penis. A Useful Guide For The Management Of Inguinal Lymph Node Dissections. (612) AL Cubilla, EF Velazquez, JE Barreto, A Chaux, C Caballero - Instituto de Patologia e Investigacion, Asuncion, Paraguay; NYU School of Medicine, New York, NY